Beaumont Financial Partners LLC increased its stake in shares of Danaher Corporation (NYSE:DHR) by 0.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,388 shares of the conglomerate’s stock after acquiring an additional 84 shares during the period. Beaumont Financial Partners LLC’s holdings in Danaher Corporation were worth $4,674,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of DHR. Peddock Capital Advisors LLC grew its holdings in Danaher Corporation by 17.4% during the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 181 shares during the period. Proficio Capital Partners LLC grew its holdings in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after acquiring an additional 598 shares during the period. Acrospire Investment Management LLC grew its holdings in Danaher Corporation by 185.5% during the second quarter. Acrospire Investment Management LLC now owns 1,693 shares of the conglomerate’s stock worth $143,000 after acquiring an additional 1,100 shares during the period. ClariVest Asset Management LLC acquired a new stake in Danaher Corporation during the first quarter worth about $157,000. Finally, Motco grew its holdings in Danaher Corporation by 8.8% during the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after acquiring an additional 163 shares during the period. 75.66% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Beaumont Financial Partners LLC Has $4.67 Million Position in Danaher Corporation (DHR)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/21/beaumont-financial-partners-llc-has-4-67-million-position-in-danaher-corporation-dhr.html.

In related news, insider William King sold 43,688 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $82.86, for a total value of $3,619,987.68. Following the sale, the insider now owns 45,748 shares in the company, valued at approximately $3,790,679.28. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $81.78, for a total value of $799,154.16. Following the completion of the sale, the insider now owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. Corporate insiders own 12.20% of the company’s stock.

Danaher Corporation (NYSE:DHR) opened at 90.79 on Friday. The stock has a market cap of $63.07 billion, a P/E ratio of 28.98 and a beta of 1.03. Danaher Corporation has a 52-week low of $76.27 and a 52-week high of $91.64. The stock has a 50 day moving average price of $86.59 and a 200 day moving average price of $84.29.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.05. The business had revenue of $4.53 billion for the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.48% and a net margin of 13.36%. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.87 EPS. On average, equities research analysts forecast that Danaher Corporation will post $3.97 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.62%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is currently 16.52%.

Several analysts recently commented on the company. Robert W. Baird raised their target price on Danaher Corporation from $87.00 to $97.00 and gave the stock an “outperform” rating in a report on Friday. Morgan Stanley raised their target price on Danaher Corporation from $95.00 to $98.00 and gave the stock an “overweight” rating in a report on Friday. Credit Suisse Group raised their target price on Danaher Corporation from $93.00 to $96.00 and gave the stock an “outperform” rating in a report on Friday. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research report on Thursday, October 5th. Finally, J P Morgan Chase & Co reiterated an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, September 8th. One analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $93.31.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.